ON-DEMAND WEBINARS

During this virtual presentation from the 2020 Digital Biomarkers & Digital Measurements Summit, industry thought leaders from ActiGraph, Atlantic Council, Elektra Labs, and NeuroLogica answer key questions around the evaluation and evidence required to select digital clinical measures.

Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

Discover a trial feasibility tool that integrates users' operational insights with high-quality clinical intelligence to drive accurate and informed enrollment projections and site capacity analyses.

What if AI could spot risks and connect fragmented data before issues arise? Learn how agentic AI may help clinical teams shift from reactive problem-solving to proactive decisions.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor